Exosome Seminar

Exosome Seminar

By Kimera Labs

Date and time

Saturday, July 13, 2019 · 8am - 6pm PDT

Location

Caesars Palace Conference Center Verona/Trevi/Turin Rooms

3570 S Las Vegas BLVD Las Vegas, NV 89109

Description

Join us for a One day Intensive Clinical Education and Training on Exosomes featuring world leading experts:

Doug Spiel, M.D.
Duncan Ross, Ph.D.
Jason Sanders, M.D.


Doug Spiel, M.D.

A clinical physician who is board-certified in both diagnostic radiology and interventional pain medicine. His extensive knowledge in both these fields coupled with his understanding of the physiological basis of stem cell therapy has made him a unique presence on the educational landscape of regenerative medicine. Dr. Spiel lectures nationally for some of the most respected societies including the American Academy of Anti-Aging Medicine, the American Society of Interventional pain Physicians, Boston BioLife, Advanced Regenerative Medicine Institute, the American Association of Stem Cell Physicians and numerous state societies. Dr. Spiel serves on the editorial board of Pain Physician, section editor of Interventional Pain Management Reports and is a board member of the American Association of Stem-Cell Physicians. As an expert in Endoscopic Spine surgery, Diagnostic Radiology, Interventional pain and regenerative medicine, his novel treatment strategies serve as the standards for exosome therapy. Dr. Spiel has successfully treated numerous diverse pathologies ranging from central nervous system disease to alopecia, autoimmune disease and various spinal and musculoskeletal conditions.


Duncan Ross, Ph.D.

Dr. Duncan Ross is an expert in stem cell culture and has developed and patented proprietary methods of stem cell manipulation and licensing using growth factors and nucleic acids. A native of Miami Beach, Florida, Dr. Ross earned a Bachelor of Science in Microbiology and Immunology and a Ph.D. in Immunology/Biochemistry from the University of Miami in Coral Gables, Florida, where his research focused on mechanisms of suppression of graft vs. host disease in minor antigen mismatched allogeneic hematopoietic stem cell transplantation. As founder of Kimera Labs, Inc., Dr. Ross’s work is focused on controlling disease with immunological molecular approaches, in particular, exosome isolation from perinatal cells and amniotic fluid. As a pioneer in the development of cell-free exosome products, Dr. Ross’s research has been and continues to be employed by many physicians and clinics in a variety of regenerative medicine protocols. Dr. Ross has been featured in various peer reviewed publications including “Blood” and “Biology of Blood and Marrow Transplantation”, in which he discussed the use of various cell types to suppress immunological diseases, and currently has a patent pending for wound healing exosomes. Dr. Ross is also the founding board member of the federal nonprofit research organization, The Kimera Society, which has developed a number of clinical partners in the US and abroad by serving as an educational conduit for clinics.


Jason Sanders, MD

Board-Certified Orthopedic Surgeon Exosome Technology Developer Dr. Sanders graduated from Harvard University with an Honors degree in Biochemical Sciences. The focus of his undergraduate degree was molecular biochemistry and cellular signaling. Dr. Sanders graduated from the University of Miami School of Medicine and was inducted into the Alpha Omega Alpha medical honor society. He completed his residency in orthopaedic surgery at the University of Miami/Jackson Memorial Hospital and did a fellowship in shoulder, elbow and hand surgery. After building a successful subspecialty practice in upper extremity surgery over 10 years, Dr. Sanders shifted his focus to developing minimally-invasive regenerative techniques. With a holistic view of systemic rejuvenation, he has developed techniques using lasers, broadband light and advanced biologics to regenerate multiple organ systems including the musculoskeletal system and the skin. Dr. Sanders is currently involved in further development of exosome technologies and physician education.

Organized by

XoGlo, the original purified exosome

XoGlo is the first purified, isolated, GMP produced placental mesenchymal stem cell exosome available to the clinician since its discovery in 2014 in the first Kimera Lab.  Founded in 2012 by Duncan Ross Ph.D., a published BMT transplant scientist, Kimera Labs and Kimera Society originated the field of clinical MSC exosome production, characterization and isolation in the US. Now operating a 27,000 sq ft facility solely dedicated to exosome production, Kimera Labs has treated over 35,000 patients without an adverse event, and with our first FDA IND application in 2020, Kimera has established itself as the standard to which the developing exosome industry conforms while leading the way towards a production platform capable of serving the mass market.

Sales Ended